Novel Chemical and Biological Agents in the Treatment of Pain and Substance Use Disorders
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: 31 July 2024 | Viewed by 2303
Special Issue Editors
Interests: pain; addiction; opioids; GPCRs; synthesis; self-administration; drug discrimination
Interests: drug abuse and addiction; pain anxiety; medicinal chemistry; natural products; drug development
Special Issue Information
Dear Colleagues,
In the United States, drug overdose is one of the leading causes of death in adults aged 50 and under. In 2017, over 750,000 drug overdose deaths worldwide were attributed to drug abuse or substance use disorder. More than 70% of these deaths were due to opioids. Effective treatments for substance use disorder will help reduce these preventable deaths. In addition to the health impact of substance abuse on the individuals and their families, illicit drug use has a huge economic burden, estimated to cost about USD 193 billion in the United States alone. Thus, there is the need for novel molecules as treatments for substance use disorder. Moreover, there is a need for novel treatments for pain that do not have abuse liabilities. This Special Issue is dedicated to highlighting recent advancements in substance abuse and pain research. The scope includes, but is not limited to, the discovery and development of novel compounds to treat pain and substance use disorders, new therapeutic strategies for treating pain and substance use disorders, insights into mechanisms of pain and drug addiction, and the development of new behavioral models to treat substance use disorders. Original research articles, short communications, and review articles are welcomed.
Dr. Samuel Obeng
Prof. Dr. Christopher R. McCurdy
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- addiction
- substance use disorder
- pain
- opioids
- cannabinoids
- stimulants
- depressants
- hallucinogens
